Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F I Toro

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
G.E.N|July 1, 1989
[Molecular biology techniques for detection of delta hepatitis virus. I: Obtaining the specific diagnostic probe]F I Toro, J L Ramírez, N E Bianco, et al.
Viral Immunology|January 1, 1994
CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.
Journal of Medical Virology|December 1, 1992
Assessment of former and newly developed HBV assays in a Third World settingM E Zabaleta, F I Toro, M E Ruiz, et al.
Progress in Clinical and Biological Research|January 1, 1991
Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virusI V Machado, L Deibis, M Zabaleta, et al.
Clinical Immunology and Immunopathology|November 1, 1993
Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsM L Baroja, F L Sirit, D J Caldera, et al.
G.E.N|July 1, 1994
[Immunoclinical, molecular and immunopathologic approach to chronic viral hepatitis. Therapeutic considerations]I V Machado, L Deibis, E Risquez, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
G.E.N|July 1, 1989
[Molecular biology techniques for detection of delta hepatitis virus. I: Obtaining the specific diagnostic probe]F I Toro, J L Ramírez, N E Bianco, et al.
Viral Immunology|January 1, 1994
CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.
Journal of Medical Virology|December 1, 1992
Assessment of former and newly developed HBV assays in a Third World settingM E Zabaleta, F I Toro, M E Ruiz, et al.
Progress in Clinical and Biological Research|January 1, 1991
Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virusI V Machado, L Deibis, M Zabaleta, et al.
Clinical Immunology and Immunopathology|November 1, 1993
Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsM L Baroja, F L Sirit, D J Caldera, et al.
G.E.N|July 1, 1994
[Immunoclinical, molecular and immunopathologic approach to chronic viral hepatitis. Therapeutic considerations]I V Machado, L Deibis, E Risquez, et al.
Pageof 1